Report: Nets to send Jae Crowder to Bucks for five second-round picks

Reuters

Health Rounds: New drug could change the course of strokes

Thousands of doctors and researchers involved in the care of patients with stroke around the world have gathered in Dallas or are tuning in virtually for the three-day American Stroke Association’s International Stroke Conference. An experimental medication designed to shield brain tissue from inflammation damage led to lower rates of death and disability in stroke patients in a mid-stage trial, researchers reported on Wednesday at the International Stroke Conference in Dallas. “If the results are confirmed with larger studies, it will mean that we can effectively treat patients with neuroprotectants, in addition to current standard treatments to restore blood flow,” Macarena Hernandez of Madrid-based ataTargets SL., the company developing the drug, said in a statement.